The potential of emerging non-animal models for medical product development
Tracks
Track 2
Friday, November 1, 2024 |
12:35 PM - 1:20 PM |
Room 109 |
Details
This conference session will explore the transformative potential of emerging non-animal models in medical product development. Participants will gain insights into how these innovative approaches can complement or replace traditional animal methods, enhancing research quality and productivity while addressing ethical concerns. The session will highlight specific opportunities for Australia to strengthen its capabilities, improve sovereign capacity, and tap into new revenue streams in the burgeoning global non-animal testing market, projected to grow significantly through 2025. Expert speakers will discuss recent policy shifts in the U.S. and Europe that encourage the transition away from animal use, along with real-world applications of non-animal models that identify unsuitable medical products earlier in the development process. Join us to engage in a dynamic dialogue about the future of ethical research, aligning with the global ‘3Rs’ objectives to replace, reduce, and refine animal use in testing
Speaker
Dr Martin Engel
Senior Business Development Manager, APAC; Principal Scientist
Inventia Life Science Pty Ltd
Panellist
Dr. Kim Fung
Principal Research Scientist
CSIRO
Chair
Dr. Alastair King
Head of Biology
Eurofins Discovery
Panellist
Ms Leanne Weekes
Director of Research, Policy & Advocacy
Bellberry